Search

Your search keyword '"Kim, Suhnggwon"' showing total 397 results
Start Over Author "Kim, Suhnggwon"
397 results on '"Kim, Suhnggwon"'

1. Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants

Author

Hwang, Jin Ho, primary, Oh, Sohee, additional, Chin, Ho Jun, additional, Kim, Sejoong, additional, Kim, Dong Ki, additional, Kim, Suhnggwon, additional, Park, Jung Hwan, additional, Shin, Sung Joon, additional, Lee, Sang-Ho, additional, Choi, Bum Soon, additional, and Lim, Chun Soo, additional

Published
2023
Full Text
View/download PDF

16. Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI)

Author

LI, PHILIP KAM-TAO, CHOW, KAI MING, MATSUO, SEIICHI, YANG, CHIH WEI, JHA, VIVEKANAND, BECKER, GAVIN, CHEN, NAN, SHARMA, SANJIB KUMAR, CHITTINANDANA, ANUTRA, CHOWDHURY, SHAFIQUL, HARRIS, DAVID C.H., HOOI, LAI SEONG, IMAI, ENYU, KIM, SUHNGGWON, KIM, SUNG GYUN, LANGHAM, ROBYN, PADILLA, BENITA S., TEO, BOON WEE, TOGTOKH, ARIUNAA, WALKER, ROWAN G., WANG, HAI YAN, and TSUKAMOTO, YUSUKE

Published
2011
Full Text
View/download PDF

18. P0151SEXUAL DIMORPHISM IN HYPERTENSION ACCORDING TO THE CHANGE OF URINE SODIUM AND VOLUME EXCRETION BY SEX OR MENOPAUSE

Author

Kim, Yang-Gyun, primary, KIM, MI JI, primary, CHO, WON HEE, primary, Moon, Ju-Young, primary, Jeong, Kyung Hwan, primary, Hwang, Hyeon Seok, primary, Kim, Jin Sug, primary, Lee, Sang-Ho, primary, Hwang, Jin Ho, primary, Kim, Sejoong, primary, CHIN, HO JUN, primary, Kim, Dong Ki, primary, Kim, Suhnggwon, primary, Park, Jung Hwan, primary, Shin, Sung Joon, primary, Choi, Bum Soon, primary, and Lim, Chun Soo, primary

Published
2020
Full Text
View/download PDF

42. The association of moderate renal dysfunction with impaired preference-based health-related quality of life: 3rd Korean national health and nutritional examination survey

Author

Lee Hajeong, Oh Yun Jung, Kim Myounghee, Kim Ho, Lee Jung Pyo, Kim Sejoong, Oh Kook-Hwan, Jun Chin Ho, Joo Kwon Wook, Lim Chun Soo, Kim Suhnggwon, Kim Yon Su, and Kim Dong Ki

Subjects
Chronic kidney disease, EuroQol-5D, Preference-based health utility, Diseases of the genitourinary system. Urology, RC870-923
Abstract

Abstract Background Only a few large-scale studies have investigated the association between health-related quality of life (HRQOL) and renal function. Moreover, the HRQOL of patients with moderate renal dysfunction is frequently underestimated by healthcare providers. This study assessed the impact of renal function on preference-based HRQOL in Korean adult population. Methods We analyzed data for 5,555 adults from the 3rd Korean National Health and Nutritional Examination Survey 2005. The EuroQol-5D (EQ-5D) utility score was used to evaluate HRQOL. The study subjects were stratified into three groups based on their estimated glomerular filtration rates (eGFRs): ≥ 90.0, 60.0-89.9 and 30.0-59.9 mL/min/1.73 m2. Individuals with advanced renal dysfunction were excluded from the analysis. Results The proportions of participants who reported problems in each of the five EQ-5D dimensions increased significantly with decreasing eGFR. However, a significant decrease in the EQ-5D utility score was observed among participants with an eGFR of 30.0-59.9 mL/min/1.73 m2. Participants with an eGFR of 30.0-59.9 mL/min/1.73 m2 had an almost 1.5-fold higher risk of impaired health utility (the lowest quartile of EQ-5D utility score) compared with those participants with eGFRs ≥ 90.0 mL/min/1.73 m2, after adjustment for age, gender, health-related behaviors, socioeconomic and psychological variables, and other comorbidities. Among the five dimensions of the EQ-5D, an eGFR of 30.0-59.9 mL/min/1.73 m2 was an independent determinant of self-reported problems in the mobility and pain/discomfort dimensions. Conclusions Although age affects the association between renal dysfunction and the EQ-5D, moderate renal dysfunction seems to be an important determinant of impaired health utility in a general population and may affect the mobility and pain/discomfort dimensions of health utility.

Published
2012
Full Text
View/download PDF

43. Effects of Sustained‐Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study Results

Author

Nakamoto, Hidetomo, primary, Yu, Xue‐Qing, additional, Kim, Suhnggwon, additional, Origasa, Hideki, additional, Zheng, Hongguang, additional, Chen, Jianghua, additional, Joo, Kwon Wook, additional, Sritippayawan, Suchai, additional, Chen, Qinkai, additional, Chen, Hung‐Chun, additional, Tsubakihara, Yoshiharu, additional, Tamai, Hirofumi, additional, Song, Sang Heon, additional, Vaithilingam, Indralingam, additional, Lee, Kang Wook, additional, Shu, Kuo‐Hsiung, additional, Hok‐King Lo, Stanley, additional, Isono, Masanao, additional, Kurumatani, Hajimu, additional, Okada, Kiyonobu, additional, Kanoh, Hiroyuki, additional, Kiriyama, Takashi, additional, Yamada, Shunsuke, additional, and Fujita, Toshiro, additional

Published
2019
Full Text
View/download PDF

44. Estimating the urinary sodium excretion in patients with chronic kidney disease is not useful in monitoring the effects of a low-salt diet

Author

Kim, Se-Yun, primary, Lee, Yu Ho, additional, Kim, Yang-Gyun, additional, Moon, Ju-Young, additional, Chin, Ho Jun, additional, Kim, Sejoong, additional, Kim, Dong Ki, additional, Kim, Suhnggwon, additional, Park, Jung Hwan, additional, Shin, Sung Joon, additional, Choi, Bum Soon, additional, Lim, Chun Soo, additional, Lee, Minjung, additional, and Lee, Sang-ho, additional

Published
2018
Full Text
View/download PDF

47. Quality of life and mortality from a nephrologist's view: a prospective observational study

Author

Chae Dong-Wan, Na Ki, Kim Ki, Han Seung, Kim Yon, Kim Suhnggwon, and Chin Ho

Subjects
Diseases of the genitourinary system. Urology, RC870-923
Abstract

Abstract Background Although health-related quality of life (HRQOL) is a potential independent predictor of mortality, nephrologists have shown little interest in HRQOL with respect to mortality in chronic kidney disease (CKD). The aim of this article is to evaluate the impact of HRQOL on mortality in the elderly, who are likely to develop or already have CKD. Methods Among 1,000 randomly sampled participants aged more than 65 years (sourced from the Korean Longitudinal Study on Health and Ageing), 944 subjects were evaluated for HRQOL. HRQOL was assessed using a 36-item Short-Form health survey (SF36). A cumulative survival rate was calculated according to tertiles of SF36 scores and classified by the presence of CKD (estimated GFR 2). Results Among 944 subjects, 46.6% had CKD. CKD patients had lower total and physical component scores compared with subjects without CKD. The 3-year cumulative survival rate was 90.0% (non-CKD vs. CKD: 92.6% vs. 87.4%, P = 0.005 by log rank test). After adjusting for multiple variables, a reduced SF36 score (physical and mental components) was a strong predictor of all-cause mortality. Physical components were consistently able to predict mortality after CKD classification, but mental components were statistically significant only in the CKD group. Conclusion In addition to traditional risk factors of mortality, nephrologists should be aware of HRQOL as a predictor of mortality and should make efforts to improve HRQOL in CKD patients.

Published
2009
Full Text
View/download PDF

48. Effects of Sustained‐Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study Results.

Author

Nakamoto, Hidetomo, Yu, Xue‐Qing, Kim, Suhnggwon, Origasa, Hideki, Zheng, Hongguang, Chen, Jianghua, Joo, Kwon Wook, Sritippayawan, Suchai, Chen, Qinkai, Chen, Hung‐Chun, Tsubakihara, Yoshiharu, Tamai, Hirofumi, Song, Sang Heon, Vaithilingam, Indralingam, Lee, Kang Wook, Shu, Kuo‐Hsiung, Hok‐King Lo, Stanley, Isono, Masanao, Kurumatani, Hajimu, and Okada, Kiyonobu

Subjects
DRUG side effects, CHRONIC kidney failure, CONTROLLED release preparations, KIDNEY glomerulus diseases, CHRONICALLY ill, ADVERSE health care events
Abstract

TRK‐100STP, a sustained‐release preparation of the orally active prostacyclin analogue beraprost sodium, targets renal hypoxia. This study aimed to show the superiority of TRK‐100STP over placebos in patients with chronic kidney disease (with either primary glomerular disease or nephrosclerosis) to determine the recommended dose. CASSIOPEIR (Chronic Renal Failure Asian Study with Oral PGI2 Derivative for Evaluating Improvement of Renal Function) was a randomized, double‐blind, placebo‐controlled study conducted at 160 sites in seven Asia‐Pacific countries and regions. Eligible patients (n = 892) were randomized to TRK‐100STP 120, 240 μg, or placebo for a treatment period of up to 4 years. The primary efficacy endpoint was time to first occurrence of a renal composite: doubling of serum creatinine or occurrence of end‐stage renal disease. No significant differences were observed in composite endpoints between TRK‐100STP and placebo (P = 0.5674). Hazard ratios (95% CI) in the TRK‐100STP 120 and 240 μg vs. placebo groups were 0.98 (0.78, 1.22) and 0.91 (0.72, 1.14), respectively. The overall incidence of adverse events and adverse drug reactions was comparable between treatment arms. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results